Solid-state of pharmaceutical compounds impact of the ICH Q6 guideline on industrial development

Journal of Thermal Analysis and Calorimetry

Volumn 77, Issue 2, 2004, Pages 709-747

  Giron, D ^a   Mutz, M ^a   Gamier, S ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Amorphous forms; Design of the solid state; Hydrates; Kinetics; Monitoring; Pharmaceuticals; Physical analytical methods; Polymorphism; Quantification; Solid state properties; Solid state transformations; Solvates; Thermodynamic relationships

Indexed keywords

AMORPHOUS FORMS; DESIGN OF THE SOLID-STATE; PHYSICAL ANALYTICAL METHODS; POLYMORPHISM; SOLID-STATE PROPERTIES; SOLID-STATE TRANSFORMATIONS; SOLVATES; THERMODYNAMIC RELATIONSHIPS;

CRYSTAL STRUCTURE; HYDRATES; MONITORING; PRODUCT DESIGN; PRODUCT DEVELOPMENT; REACTION KINETICS; THERMODYNAMICS;

DRUG PRODUCTS;

EID: 4344717272     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JTAN.0000039005.51343.33     Document Type: Conference Paper

References (124)

1. J. K. Haleblian and W. J. McCrone, Pharmaceutical applications of polymorphism. Pharm. Sci., 58 (1969) 911.
2. J. K. Haleblian, Pharm. Sci., 64 (1975) 1269.
3. D. Giron, Labo-Pharma-Probl. Techn., 307 (1981) 151.
4. D. Giron, S. T. P. Pharma, 4 (1988) 330.
5. D. J. W. Grant, Theory and Origin of Polymorphism. In: Polymorphism in Pharmaceutical Solids. H. G. Brittain Ed., Marcel Dekker, New York, 1999, pp. 1-34.
6. D. Giron, Thermochim. Acta, 248 (1995) 1.
7. J. Masse, M. Bauer, P. Billot, M. Broquaire, A. Chauvet, J. Doveze, O. Garinot, D. Giron and C. Popoff, S: T. P. Pharma Pratiques, 7 (1997) 235.
8. nd ed., SSCI Inc., West Lafayette, Indiana, 1999.
9. International Conference on Harmonization (ICH), Guideline Specification Q6A, October 1999.
10. W. H. DeCamp, Amer. Pharm. Rev., 4 (2001) 70.
11. L. X. Yu, M. S. Fumes, A. Raw, K. P. Woodland Outlaw, N. E. Nashed, E. Ramos, S. P. F. Miler, R. C. Adams, F. Fang, R. M. Patel, F. O. Holcombe, Y. Chiu and A. S. Hussain, Pharm. Res., 20 (2003) 531.
12. S. A. Raw, M. S. Furness, D. S. Gill, R. C. Adams, F. O. Holcombe, L. Yu, Adv. Drug Del. Rev., 56 (2004) 397.
13. S. R. Chemburkar, J. Bauer, K. Deming, H. Spiwek, K. Patel, J. Morris, R. Henry, S. Spanton, W. Dziki, W. Porter, J. Quick, P. Bauer, J. Donaubauer, B. A. Narayanan, M. Soldani, D. Riley and K. McFarland, (Ritonavir), Org. Proc. Res. Dev., 4 (2000) 413.
14. M. Bauer, S. T. P. Pharma Pratiques, 13 (2003) 47.
15. A. W. Newman and S. Byrn, Drug Discovery Today, 8 (2003) 898.
16. D. Giron, Monitoring of Polymorphism - From Detection to Quantification. Engineering in Life Sciences, 3 (2003) 103.
17. D. Giron, J. Therm. Anal. Cal., 73 (2003) 441.
18. D. Giron and D. J. W. Grant in Handbook of Pharmaceutical Salts, 'Properties, Selection and Use',. P. H. Stahl and C. G. Wermuth Eds, IUPAC, Wiley-VCH, Verlag Helvetica Chimica Acta, Zürich, 2002, Ch. 3 pp. 42-81.
19. S. R. Vippagunta, H. G. Brittain and D. J. W. Grant, Adv. Drug Deliv. Rev., 48 (2001) 3.
20. General Pharmaceutics E. F. 'Gene Fiesé' J. Pharm. Sci., 92 (2003) 1331.
21. N. Blagden and R. J. Davey, 'Polymorph selection challenge for the future'. Crystal Growth & Design, 3 (2003) 873.
22. S. Briancon and H. Fessi, S. T. P. Pharma Pratiques, 13 (2003) 215.
23. S. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg and G. Poochikian, Pharm. Res., 12 (1995) 945.
24. W. Beckmann, Eng. Life Sci., 3 (2003) 113.
25. N. Rodriguez-Hornedo and D. Murphy, J. Pharm. Sci., 88 (1999) 651.
26. M. Kitamura, J. Crystal Growth, 237 (2002) 2205.
27. S. Veesler, L. Lafferrere, E. Garcia and C. Hoff, Organic Proc. Res. & Dev., 7 (2003) 983.
28. J. F. Remenar, J. M. MacPhee, B. K. Larson, V. A. Tyagi, J. H. Ho, D. A. Mcllroy, M. B. Hickey, P. B. Shaw and O. Almarsson, Organic Process RID, 7 (2003) 990.
29. S. L. Morisette, O. Almarsson, M. L. Peterson, J. F. Remenar, M. J. Read, A. V. Lemmo, S. Ellis, M. J. Cima and C. R. Gardner, Adv. Drug Del. Rev., 56 (2004) 275.
30. S. Balbach and C. Korn, Int. J. Pharm., 275 (2004) 1.
31. J. D. Dunitz and J. Bernstein, Ace. Chem. Res., 28 (1995) 193.
32. D. Giron, J. Therm. Anal. Cal., 64 (2001) 37.
33. D. Giron, M. Draghi, C. Goldbronn, S. Pfeffer and P. Piechon, J. Thermal Anal., 49 (1997) 913.
34. D. Giron, P. Piechon, C. Goldbronn and S. Pfeffer, J. Therm. Anal. Cal., 57 (1999) 61.
35. D. Giron, J. Therm. Anal. Cal., 56 (1999) 1285.
36. D. Giron, J. Therm. Anal. Cal., 68 (2002) 335.
37. A. Burger and R. Ramberger, Microchim. Acta, II (1979) 259.
38. S. Toscani, Thermochim. Acta, 321 (1998) 73.
39. L. Yu, J. Pharm. Sci., 84 (1995) 966.
40. D. Giron, Mol. Cryst. Liq. Cryst., 161 (1988) 77.
41. D. Giron, B. Edel and P. Piechon, Mol. Cryst. Liq. Cryst., 187 (1990) 297.
42. D. Giron, Acta Pharm. Jugosl., 40 (1990) 95.
43. H. H. Y. Tong, B. Y. Shekunov, P. York and A. H. L. Chow, Pharm. Res., 20 (2003) 1423.
44. N. Blagden, R. J. Davey, R. Rowe and R. Roberts, Int. J. Pharm., 172 (1998) 169.
45. K. Sato, K. Suzuki, M. Kada and N. Garti, J. Crystal Growth, 72 (1985) 699.
46. K. Urakami and A. E. Beezer, Int. J. Pharm., 257 (2003) 265.
47. K. R. Morris, Structural aspects of hydrates and solvates. (Polymorphism in Pharmaceutical Solids Brittain H. G. Ed., Marcel Dekker, New York), Drugs Pharm. Sci., 95 (1999) 125.
48. R. K. Kankhari and D. J. W. Grant, Thermochim. Acta, 248 (1995) 61.
49. M. Soustelle, Handbook of Powder Technology, J. C. Williams and T. Allen, Vol. 9, Powder Technology and Pharmaceutical Processes, D. Chulia, M. Deleuil and Y. Pourcelot, Eds, Elsevier (1994) 27.
50. J. Han, S. Gupte and R. Suryanarayanan, Int. J. Pharm., 170 (1998) 63.
51. J. Han and R. Suryanarayanan, Thermochim. Acta, 329 (1999) 163.
52. J. A. McCauley, R. J. Varsolona and D. A. Levorse, J. Phys. D. Appl. Phys., 26 (1993) B85.
53. S. M. Reutzel-Edens, J. K. Bush, P. A. Magu, G. A. Stephenson and S. R. Byrn, Crystal Growth Design, 3 (2003) 897.
54. D. Giron, Ch. Goldbronn, M. Mutz, S. Pfeffer, P. Piechon and P. Schwab, J. Therm. Anal. Cal., 68 (2002) 453.
55. P. DiMartino, F. Piva, P. Conflant and A. M. Guyot-Hermann, J. Therm. Anal. Cal., 57(1999)95.
56. D. Giron and C. Goldbronn, J. Thermal Anal., 49 (1997) 907 and J. Therm. Anal. Cal., 51 (1998) 727.
57. D. Giron and C. Goldbronn, J. Thermal Anal., 49 (1997) 907 and J. Therm. Anal. Cal., 51 (1998) 727.
58. H. Zhu, C. Yuen and D. J. W. Grant, Int. J. Pharm., 135 (1996) 151.
59. H. Zhu and D. J. W. Grant, Int. J. Pharm., 139 (1996) 33.
60. M. Sacchetti, Int. J. Pharm. 273 (2004) 195.
61. D. Giron, M. Bellus, S. Garnier, C. Goldbronn, P. Piechon and S. Pfeffer, 'Use of thermoanalytical combined techniques for process development' JCAT34, May 2003, Mulhouse.
62. D. Giron, Spectra Analyse, 32 (2003) 17.
63. E. Tedesco, D. Giron and S. Pfeffer, Cryst. Eng. Comm., 4 (2002) 1.
64. D. Giron, Symposium on Thermal Analysis, Calorimetry and Chemical Thermodynamics, 20 years STK, Valbella, December 1994.
65. A. Gavezotti and G. Filippini, J. Am. Chem. Soc., 118 (1996) 7153.
66. G. A. Stephenson, J. Pharm. Sci., 89 (2000) 958.
67. N. Rasenack and B. W. Muller, Drug Dev. Ind. Pharm., 28 (2002) 1077.
68. S. L. Price, Adv. Drug Del. Rev., 56 (2004) 301.
69. Drug release 〈724〉 Flow-through cell, USP 26 (2003) p. 2159.
70. G. Stowell, R. J. Bchme, S. M. Denton, I. Pfeiffer, F. D. Sancilio, L. B. Whittall and R. B. Whittle, J. Pharm. Sci., 91 (2002) 2481.
71. Intrinsic Dissolution 〈1087〉 USP 26 (2003) p. 2333.
72. R. G. Hollenbeck, J. Pharm. Sci., 69 (1980) 1241.
73. A. Burger, Acta Pharm. Technol., 28 (1982) 17.
74. H. Nyqvist, Int. J. Pharm. Techn. Prod. Mfr., 4 (1983) 47.
75. DVS (Dynamic Vapour Sorption). Surface Measurement Systems Ltd, UK.
76. S. Nordhoff and J. Ulrich, J. Therm. Anal. Cal., 57 (1999) 181.
77. H. Ando, Drug Dev. Ind. Pharm., 21 (1995) 2227.
78. M. Otsuka, M. Onoe and Y. Matsuda, Pharm. Res., 10 (1993) 577.
79. H. Kitoaka, Chem. Pharm. Bull., 43 (1995) 1744.
80. A. Weissbuch, L. Addadi, M. Lahav and L. Leiserowitz, Science, 253 (1991) 637.
81. H. Nyqvist and T. Wadsten, Acta Pharm. Technol., 32 (1986) 130.
82. K. Nord, H. Andersen and H. H. Tonnesen, Drug Stability, 1 (1997) 243.
83. G. Stephenson, R. A. Forbes and S. M. Reutzel-Edens, Adv. Drug Del. Rev., 48 (2001) 67.
84. D. E. Bugay, Adv. Drug Del. Rev., 48 (2001) 43.
85. M. Davidovich, J. Z. Gougoutas, R. P. Scaring, I. Vitéz and S. Yin, Amer. Pharm. Rev., 7 (2004).
86. S. Yin, R. P. Scaring, J. DiMarco, M. Gaella and J. Z. Gougoutas, Amer. Pharm. Rev., 6 (2003) 80.
87. S. D. Clas, R. Faizer, R. E. O'Connor and E. B. Vadas, Int. J. Pharm., 121 (1995) 73.
88. ASTME1655-00. «Standard Practice for IR quantitative Analysis», ASTM International, West Conshohocken, PA.
89. R. Helmy, G. X. Zhou, Y. W. Chen, L. Crocker, T. Wang, R. M. Wenslow and A. Vailaya, Anal. Chem., 75 (2003) 605.
90. S. Agatonovic-Kustrin, T. Rades, V. Wu, D. Saville and I. G. Tucker, J. Pharm. Biomed. Anal., 25 (2001) 741.
91. EMEA, Guideline for the development and Validation of NIR Methods in the Pharmaceutical Industry, N. Broad, P. Graham, P. Hailey, A. Hardy, S. Holland, S. Hughes, D. Lee, K. Prebble and N. Salton, 2002 Validation according to ICH. Equipment Selection and Qualification, calibration stored as part of instrument and method.
92. A. D. Patel, P. E. Luner and M. S. Kemper, J. Pharm. Sci., 90 (2001) 360.
93. M. Otsuka, F. Kato and Y. Matsuda, Analyst, 126 (2001) 1578.
94. R. S. Campbell, A. C. Williams, I. M. Grimsey and S. W. Booth, J. Pharm. Biomed. Anal., 28 (2002) 1135.
95. L. S. Taylor, Amer. Pharm. Rev., 4 (2001) 60.
96. P. A. Tishmack, D. E. Bugay and S. R. Byrn, J. Pharm. Sci., 92 (2003) 441.
97. M. T. Zell, B. E. Padden, D. J. W. Grant, S. A. Schroeder, K. L. Wachholder, I. Prakash and E. J. Munson, Tetahedron, 56 (2000) 6603.
98. D. C. Apperley, R. K. Harris, T. Larsson and T. Malmstrom, J. Pharm. Sci., 92 (2003) 2487.
99. W. Cao, P. M. Mullarney, B. C. Hancock, S. Bates and K. R. Morris, J. Pharm. Sci., 92 (2003) 2345.
100. S. Yamamura and Y. Momose, Int. J. Pharm., 259 (2003) 27.
101. M. E. Auer, U. J. Griesser and J. Sawatzki, J. Mol. Struct., 661 (2003) 307.
102. D. Pratiwi, J. P. Fawcett, K. C. Gordon and T. Rades, Eur. J. Pharm. Biopharm., 54 (2002) 3.
103. M. Blanco and A. Villar, J. Pharm. Sci., 92 (2003) 823.
104. K. Krishnan, J. R. Powell and S. L. Hill, Infrared microimaging in H. Humecki, Practical Guide to Infrared Microspectroscopy, Marcel Decker, NY, 1995, pp. 85-110.
105. T. Yoshinari, R. T. Forbes, P. York and Y. Kawashima, Int. J. Pharm., 258 (2003) 121.
106. G. McGeorge, Amer. Pharm. Rev., 6 (2003) 94.
107. K. A. Bakeev, Spectroscopy, 19 (2004) 39.
108. G. Fevotte, J. Calas, F. Puel and C. Hoff, Int. J. Pharm., 273 (2004) 159.
109. J. P. Higgins, M. S. Arrivo and R. A. Reed, J. Pharm. Sci., 92 (2003) 2303.
110. P. Dell'Orco, A. M. Diederich and J. W. Rydzak, Amer. Pharm. Rev., 5 (2002) 46.
111. F. Wang, J. A. Watcher, F. J. Antosz and K. A. Berglund, 'An Investigation of Solvent-Mediated Polymorphic Transformation of Progesterone Using In Situ Raman Spectroscopy,' Organic Process Research & Development, Vol. 4, No. 5, 2000.
112. C. Starbuck, A. Spartalis, L. Wai, J. Wang, P. Fernandez, C. M. Lindemann, G. X. Zhou and Z. Ge, Crystal Growth & Design, 2 (2002) 515.
113. G. Zhou, J. Wang, Z. Ge and Y. Sun, Amer. Pharm. Rev., 5 (2002) 74.
114. B. C. Hancock and G. Zografi, J. Pharm. Sci., 86 (1997) 1.
115. C. J. Roberts and P. G. Debenedetti, AIChE Journal, 48 (2002) 1140.
116. I. Weuts, D. Kempen, J. Peeters, G. Verreck, M. Brewster and G. Van den Mooter, Int. J. Pharm., 259 (2003) 17.
117. M. Gordon and J. S. Taylor, J. Appl. Chem., 2 (1952), pp. 493-500.
118. M. Anberg, C. Nyström and S. Castensson, Int. J. Pharm., 81 (1992) 153.
119. D. Giron, P. Remy, S. Thomas and E. Vilette, J. Thermal Anal., 48 (1997) 465.
120. K. Fiebich and M. Mutz, J. Therm. Anal. Cal., 57 (1999) 75.
121. M. Anberg, Thermochim. Acta, 248 (1995) 161.
122. H. Ahmed, G. Buckton and D. A. Rawlins, Int. J. Pharm., 130 (1996) 195.
123. K. Kawakami, T. Numa and Y. Ida, J. Pharm. Sci., 91 (2002) 417.
124. S. Garnier, D. Giron and M. Mutz, 'Study of crystallization of drug substances under solvent vapour atmosphere by microcalorimetry', PhandTA7, Innsbruck, September 2003.